Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Advances in Rheumatology (London, England)|June 14, 2025
Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseasesNicholas Black, Joshua Bradley, Fardad Soltani, et al.The International Journal of Cardiovascular Imaging|March 28, 2025
Comprehensive reference ranges for cardiovascular magnetic resonance: time to move on from single centre data?John P Farrant, Nicholas Black, Kentaro Yamagata, et al.ESC Heart Failure|January 17, 2024
Identification of heart failure hospitalization from NHS Digital data: comparison with expert adjudicationFardad Soltani, Joshua Bradley, Antonio Bonandi, et al.Journal of the American Heart Association|April 3, 2025
Development and Validation of Imaging-Free Myocardial Fibrosis Prediction Models, Association with Outcomes, and Sample Size Estimation for Phase 3 TrialsNicholas Black, Joshua Bradley, Gavin Lewis, et al.ESC Heart Failure|October 27, 2024
Considerations for drug trials in hypertrophic cardiomyopathyJohn P Farrant, Matthias Schmitt, Anna B Reid, et al.BMC Cardiovascular Disorders|July 5, 2024
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record dataFardad Soltani, David A Jenkins, Amit Kaura, et al.European Heart Journal|July 15, 2026
Trientine for hypertrophic cardiomyopathy: a phase 2 trialJohn P Farrant, Susanna Dodd, Anna Rosala-Hallas, et al.Pageof 1